Panel Discussion & Audience Roundtable: Advancing Therapeutics in Glomerular Diseases: What’s Next?
Time: 2:30 pm
day: Pre-Conference Focus Day
Details:
- Discuss the need to identify reliable surrogate markers for other glomerular diseases and potential avenues for development and standardization
- Discuss what can be learned from the established biomarkers in IgA nephropathy to improve patient outcomes in other glomerular diseases
- Examine the variability in pathology and clinical presentation among glomerular disease patients, and what strategies can be employed to ensure that new treatments can effectively address this heterogeneity
- Discuss the ethical and regulatory hurdles in designing trials for innovative therapies, explore potential trial designs that balance patient safety with the need to test new treatments, and how regulatory frameworks can support innovation